Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [13155]

New research reveals dangers of ‘anti-aging’ supplements in cancer protection

New research reveals dangers of ‘anti-aging’ supplements in cancer protection

An avatar to study paediatric brain cancer

McVie-Veronesi Award: Recognising leaders in improving cancer outcomes in LMICs - call for nominations

McVie-Veronesi Award: Recognising leaders in improving cancer outcomes in LMICs - call for nominations

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Artificial intelligence learns to make sense of childhood cancer survivors’ health care needs

Artificial intelligence learns to make sense of childhood cancer survivors’ health care needs

Chaos in lymph nodes promotes cancer

Chaos in lymph nodes promotes cancer

EBCC 2026: Early results from a trial of active surveillance for low-risk DCIS are ‘reassuring’

EBCC 2026: Early results from a trial of active surveillance for low-risk DCIS are ‘reassuring’

EBCC 2026: Tumour DNA circulating in patients’ blood after pre-surgery treatments predicts whether breast cancer will return

EBCC 2026: Tumour DNA circulating in patients’ blood after pre-surgery treatments predicts whether breast cancer...

FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or...

EBCC 2026: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive

EBCC 2026: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of...

More from ecancer